Hey, the date today’s 6-26-26. Fun.
Also, we’ve got further advances in embryo editing, Sen. Bill Cassidy is unveiling a bill to wrestle with 340B drug discounts, and we review the vibes we picked up this year at BIO.
Embryo editing advances reignite ethical debates
Scientists have used a newer, more precise form of CRISPR in early human embryos to better understand the genes at play during the earliest stages of human development. The work, published in Nature, also suggests base editing is gentler than earlier versions of CRISPR, avoiding the chromosome damage that has raised safety concerns. Still, the embryos frequently ended up as mosaics, STAT’s Andrew Joseph and Megan Molteni write, with a mix of edited and unedited cells.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
